Your browser doesn't support javascript.
loading
Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.
Zhang, Guang-Tao; Liu, Qi; Zuo, Fu-Xing; Liu, Hou-Jie; Wang, Song-Quan; Yuan, Qing; Liu, Ang-Si; Hu, Ke; Meng, Xiao-Li; Wang, Wei-Jia; Qian, Hai-Peng; Wan, Jing-Hai; Cai, Hong-Qing.
Affiliation
  • Zhang GT; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Liu Q; Department of Neurosurgery, The Second Affiliated Hospital, Anhui Medical University, Hefei, 230601, China.
  • Zuo FX; State Key Laboratory of Molecular Oncology, Center for Cancer Precision Medicine, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liu HJ; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Wang SQ; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Yuan Q; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Liu AS; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Hu K; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Meng XL; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Wang WJ; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Qian HP; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Wan JH; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Cai HQ; Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. qianhaipeng@sina.com.
BMC Cancer ; 23(1): 104, 2023 Jan 30.
Article in En | MEDLINE | ID: mdl-36717819
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Glioblastoma / Kidney Neoplasms Type of study: Prognostic_studies Limits: Aged / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Glioblastoma / Kidney Neoplasms Type of study: Prognostic_studies Limits: Aged / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: China